Cryoport, Inc. — Director's Dealing 2026

Mar 18, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2026-03-14

Reporting Person: Sawicki Mark W (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-03-14	Common Stock	A	22845	—	Acquired	106932	Direct
2026-03-16	Common Stock	S	3235	$8.00	Disposed	103697	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-03-14	Stock Option (right to buy)	$8.60	A	68534	Acquired	2033-03-14	Common Stock (68534)	Direct

Footnotes

F1: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027.

F2: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.

F3: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026.